Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
Mawadda Chukr, Student at Aleppo University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytokine, adding:
“My first publication is officially out in Q1
We looked at novel therapies (SYK, FcRn, and BTK inhibitors) for adult Immune Thrombocytopenia (ITP) through a systematic review and meta-analysis of 10 RCTs.
I am so grateful to my co-authors for this amazing collaboration.
Check out the graphic below for our key highlights, or read the full paper via the link!”
Title: Efficacy and safety of IgG-pathway inhibitors in adult immune thrombocytopenia: A systematic review and meta-analysis with subgroup analyses of FcRn and SYK inhibitors
Authors: Mousa Almasalma, Ahmed Hamdy Kandil, Mahmoud Hashem Al-Qadi, Mohamed Lotfy Maarouf, Sara Mohammad Altaamreh, Weaam A. Soliman, Ahmed S. Mohamed, Ahmed Boshta, Nereen A. Almosilhy, Bashar Zahir Alsalhen, Mawadda Chukr
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge